Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas
NCT01497860
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
13
Enrollment
OTHER
Sponsor class
Conditions
Low-grade Glioma
Interventions
DRUG:
Vinorelbine
Sponsor
Eugene Hwang